Top 10 search results for "" in Treatments. To see all results and access other features, sign up for free.

Apokyn (Apomorphine)

Overview
Apokyn is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2004 to treat intermittent “off” episodes in people with advanced Parkinson’s disease. Apokyn is also referred to by its… read more

Trihexyphenidyl

Overview
Trihexyphenidyl is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in all forms of parkinsonism. Trihexyphenidyl is often prescribed to younger people with… read more

Cogentin (Benztropine mesylate)

Overview
Cogentin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat motor symptoms in all forms of parkinsonism. Cogentin is often prescribed to younger people with Parkinson’s… read more

Azilect (Rasagiline)

Overview
Azilect is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2006 to treat motor symptoms in people with Parkinson’s disease. Azilect may be prescribed as a monotherapy to people… read more

Duopa (Levodopa/Carbidopa)

Overview
Duopa is a prescription drug approved by the Food and Drug Administration (FDA) in 2015 to treat fluctuating motor symptoms in those with advanced Parkinson’s Disease. Duopa may be prescribed if your condition… read more

Comtan (Entacapone)

Overview
Comtan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjunct (add-on) drug to levodopa/carbidopa if the latter drugs begin to lose effectiveness in treating motor symptoms… read more

Levodopa/Carbidopa

Overview
Together, Levodopa and Carbidopa form a combination prescription drug originally approved by the Food and Drug Administration (FDA) in 1975. Levodopa/Carbidopa is used to treat motor symptoms of Parkinsonism… read more

Deep Brain Stimulation (DBS)

Overview
People with Parkinson’s Disease whose motor symptoms are debilitating and cannot be controlled with medications, or whose side effects from medications are severe, may be candidates for Deep Brain Stimulation… read more

Exelon (Rivastigmine)

Overview
Exelon is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2000 to treat mild to moderate dementia in people with Parkinson’s disease. Exelon may also be prescribed to treat… read more

Neupro (Rotigotine Transdermal System)

Overview
Neupro is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2007 to treat motor symptoms of Parkinson’s disease. Neupro is also referred to by its drug name, rotigotine.

Neupro… read more